Adar Poonawalla's Serum Institute To Invest 240 Million Pounds In UK

SII has also begun phase one trials in the UK of a one-dose nasal vaccine for coronavirus.

Vaccine maker the Serum Institute of India is set to invest in facilities in Britain and could even manufacture inoculations in the UK in future, Prime Minister Boris Johnson said Monday. Mr Johnson's Downing Street office said the 240 million Great British Pounds ($334 million) project would include a sales office, "clinical trials, research and development and possibly manufacturing of vaccines". The Serum Institute of India (SII) is the world's largest vaccine maker by volume, and has been at the forefront of producing the lower-cost AstraZeneca coronavirus shot. SII has also begun phase one trials in the UK of a one-dose nasal vaccine for coronavirus.